Top Markets
Coin of the day
Mendus AB (publ) Mendus AB (publ)

Mendus AB (publ)

IMMU
Classement en actions #25838
Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB... Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB (publ) until its name change in June 2022, specializes in developing immunotherapies and vaccines designed to prevent cancer recurrence. Its primary investigational compound, ilixadencel, is currently progressing through a Phase II MERECA clinical study for kidney cancer, alongside Phase I/II trials targeting liver cancer and gastrointestinal stromal tumors. Additionally, the company is advancing DCP-001, which is undergoing Phase II ADVANCE-II clinical research for acute myeloid leukemia and Phase I/II ALISON trials for ovarian cancers. Mendus maintains research partnerships with PCI Biotech Holding ASA to explore novel cancer vaccination approaches and with the Icahn School of Medicine at Mount Sinai. Founded in 2002, Mendus AB is headquartered in Stockholm, Sweden.
Prix de l'action
$0.74834668
Capitalisation boursière
$45.86M
Changement (1 jour)
-0.15%
Changement (1 an)
-6.28%
Pays
SE
Échange Mendus AB (publ) (IMMU)

Catégorie

Le prix IMMU avec la capitalisation boursière de B
Mendus AB (publ) Mendus AB (publ)
IMMU
$0.74834668
Capitalisation boursière de Mendus AB (publ)(IMMU)
Capitalisation boursière: $45.86M
En August 2026, Mendus AB (publ) a une capitalisation boursière de $45.86M. Cela fait de Mendus AB (publ) la 25838th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Mendus AB (publ) du 2013 au 2026
IMMU par rapport au top 5 des plus populaires stocks
Prix pour IMMU L’actif B La capitalisation boursière de B Résultats
Mendus AB (publ) Mendus AB (publ)
$85,778.59 $45.86M
$5.257T +11,462,312.92%
Mendus AB (publ) Mendus AB (publ)
$75,038.43 $45.86M
$4.599T +10,027,128.07%
Mendus AB (publ) Mendus AB (publ)
$67,009.10 $45.86M
$4.107T +8,954,186.11%
Mendus AB (publ) Mendus AB (publ)
$58,371.77 $45.86M
$3.577T +7,799,997.77%
Mendus AB (publ) Mendus AB (publ)
$45,808.16 $45.86M
$2.807T +6,121,148.29%